世界の敗血症診断市場2021-2027:製品別(血液培養培地、ソフトウェア、機器、アッセイキット・試薬)、技術別、病原体別、検査タイプ別

◆英語タイトル:Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Blood Culture Media, Software, Instruments, Assay Kits & Reagents), By Technology, By Pathogen, By Testing Type, And Segment Forecasts, 2021 - 2027
◆商品コード:GV21MA024
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年2月26日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の敗血症診断市場規模が2027年までに11.8億ドルに達すると予測しています。2021年から2027年までに年平均9.5%成長する見通しです。本調査レポートでは、敗血症診断の世界市場について広く調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、製品別(器具、血液培養培地、アッセイキット・試薬、ソフトウェア)分析、技術別(微生物学、分子診断、免疫学的検査、フローサイトメトリー)分析、病原体別(細菌性敗血症、真菌性敗血症、その他)分析、検査タイプ別(実験室検査、PoC検査)分析、地域別分析、企業情報など、以下の構成でまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・競争分析
・敗血症診断の世界市場規模:製品別(器具、血液培養培地、アッセイキット・試薬、ソフトウェア)
・敗血症診断の世界市場規模:技術別(微生物学、分子診断、免疫学的検査、フローサイトメトリー)
・敗血症診断の世界市場規模:病原体別(細菌性敗血症、真菌性敗血症、その他)
・敗血症診断の世界市場規模:検査タイプ別(実験室検査、PoC検査)
・敗血症診断の世界市場規模:地域別
・企業情報
【レポートの概要】

Sepsis Diagnostics Market Growth & Trends

The global sepsis diagnostics market size is expected to reach USD 1.18 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.5% from 2021 to 2027. The high prevalence of sepsis, the introduction of technologically advanced diagnostic systems, and increasing government initiatives are expected to propel market growth over the forecast period.

Sepsis is a bloodstream disease that occurs as a result of a response to pathogenic microorganisms present in the blood. Patients suffering from this disease experience severe inflammation, which leads to prolonged hospitalization. According to the WHO, around 30 million people are estimated to be affected by this disease every year. The NCBI stated that the largest number of this condition has been observed in the youngest and oldest age groups. Thus, there is a rising need for the early diagnosis of this disease. The WHO reported that every year, 1.2 million children and 3 million newborns are affected by this disease across the world. This has further boosted the demand for its diagnostic tools for quick results and improved patient outcomes.

Increasing regulatory approval and the introduction of technologically advanced diagnostic solutions for sepsis are expected to facilitate market growth over the forecast period. In May 2018, T2 Biosystems, Inc., a U.S.-based emerging diagnostic solutions company, received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens.

The outbreak of COVID-19 is another important factor boosting the demand for sepsis diagnostics around the globe. Symptoms of sepsis such as multiorgan injuries develop in around 2.0% to 5.0% of COVID-19 cases 8 to 10 days post-hospitalization, based on the estimates of the Global Sepsis Alliance. To manage this situation, the Biomedical Advanced Research and Development Authority, in May 2020, extended its partnership with Beckman Coulter for the development of a digital algorithm to detect sepsis in patients with COVID-19.

Sepsis Diagnostics Market Report Highlights

• By product, blood culture media held the largest share in 2020 as it is the most accurate mode of testing for the diagnosis of this disease. The software segment is anticipated to witness the fastest growth over the forecast period owing to new product developments in this field

• On the basis of technology, the molecular diagnostics segment is anticipated to exhibit a lucrative CAGR over the forecast period owing to its high sensitivity, accuracy, and less turnaround time

• Based on the pathogen, in 2020, the bacterial sepsis segment held the largest revenue share owing to its high prevalence

• North America dominated the market in 2020 due to high awareness, a favorable reimbursement scenario, and the presence of established players

• The Asia Pacific is projected to witness lucrative growth over the forecast period owing to the presence of a large target population in emerging economies, such as India and China

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Sepsis Diagnostics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increase in the prevalence of sepsis
3.3.1.2 Rise in the incidence of hospital-acquired infections
3.3.1.3 Increase in the number of pneumonia cases
3.3.1.4 Approval and launch of advanced sepsis diagnostic systems
3.3.2 Market Restraint Analysis
3.3.2.1 High cost of automated diagnostic instruments
3.3.2.2 Lack of awareness about sepsis
3.3.3 Industry challenges
3.3.3.1 Scientific and clinical challenges associated with sepsis
3.4 Sepsis Diagnostics Market Analysis Tools
3.4.1 Industry analysis – Porter’s
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Substitution Threat
3.4.1.4 Threat from new entrants
3.4.1.5 Competitive Rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Environmental Landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal Landscape
3.4.3 Major deals and strategic alliances analysis
3.4.3.1 Joint ventures
3.4.3.2 Mergers and acquisitions
3.4.3.3 Licensing and partnership
3.4.3.4 Technology collaborations
3.4.3.5 Strategic Divestments
Chapter 4 Sepsis Diagnostics Market – Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2020
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Competitive dashboard analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis
Chapter 5 Sepsis Diagnostics Market: Product Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Product Market Share Analysis, 2020 & 2027
5.3 Segment Dashboard
5.4 Global Sepsis Diagnostics Market, by Product, 2016 to 2027
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
5.5.1 Instruments
5.5.1.1 Instruments Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2 Blood Culture Media
5.5.2.1 Blood Culture Media Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3 Assay Kits and Reagents
5.5.3.1 Assay Kits and Reagents Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.4 Software
5.5.4.1 Software Market Estimates and Forecasts, 2016 to 2027 (USD Million)
Chapter 6 Sepsis Diagnostics Market: Technology Estimates And Trend Analysis
6.1 Definition & Scope
6.2 Technology Market Share Analysis, 2020 & 2027
6.3 Segment Dashboard
6.4 Global Sepsis Diagnostics Market, by Technology, 2016 to 2027
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
6.5.1 Microbiology
6.5.1.1 Microbiology Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.2 Molecular Diagnostics
6.5.2.1 Molecular Diagnostics Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.3 Immunoassays
6.5.3.1 Immunoassays Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.4 Flow Cytometry
6.5.4.1 Flow Cytometry Market Estimates and Forecasts, 2016 to 2027 (USD Million)
Chapter 7 Sepsis Diagnostics Market: Pathogen Estimates And Trend Analysis
7.1 Definition & Scope
7.2 Pathogen Market Share Analysis, 2020 & 2027
7.3 Segment Dashboard
7.4 Global Sepsis Diagnostics Market, by Pathogen, 2016 to 2027
7.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
7.5.1 Bacterial Sepsis
7.5.1.1 Bacterial Sepsis Market Estimates and Forecasts, 2016 to 2027 (USD Million)
7.5.1.2 Gram-positive Bacteria
7.5.1.2.1 Gram-positive Bacteria Market Estimates and Forecasts, 2016 to 2027 (USD Million)
7.5.1.3 Gram-negative Bacteria
7.5.1.3.1 Gram-negative Bacteria Market Estimates and Forecasts, 2016 to 2027 (USD Million)
7.5.2 Fungal Sepsis
7.5.2.1 Fungal Sepsis Market Estimates and Forecasts, 2016 to 2027 (USD Million)
7.5.3 Others
7.5.3.1 Others Market Estimates and Forecasts, 2016 to 2027 (USD Million)
Chapter 8 Sepsis Diagnostics Market: Testing Type Estimates And Trend Analysis
8.1 Definition & Scope
8.2 Testing Type Market Share Analysis, 2020 & 2027
8.3 Segment Dashboard
8.4 Global Sepsis Diagnostics Market, by Testing Type, 2016 to 2027
8.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
8.5.1 Laboratory Testing
8.5.1.1 Laboratory Testing Market Estimates and Forecasts, 2016 to 2027 (USD Million)
8.5.2 PoC Testing
8.5.2.1 PoC Testing Market Estimates and Forecasts, 2016 to 2027 (USD Million)
Chapter 9 Sepsis Diagnostics Market: Regional Estimates & Trend Analysis
9.1 Regional Market Snapshot
9.2 Regional Market Share and Leading Players, 2020
9.2.1 North America
9.2.2 Europe
9.2.3 Latin America
9.2.4 Asia Pacific
9.2.5 Middle East & Africa
9.3 Market Share Analysis by Country, 2020
9.3.1 North America
9.3.1.1 U.S.
9.3.1.2 Canada
9.3.2 Europe
9.3.2.1 U.K.
9.3.2.2 Germany
9.3.2.3 Spain
9.3.2.4 France
9.3.2.5 Italy
9.3.2.6 Russia
9.3.3 Latin America
9.3.3.1 Brazil
9.3.3.2 Mexico
9.3.3.3 Argentina
9.3.4 Asia Pacific
9.3.4.1 Japan
9.3.4.2 China
9.3.4.3 India
9.3.4.4 South Korea
9.3.4.5 Singapore
9.3.4.6 Australia
9.3.5 Middle East & Africa
9.3.5.1 South Africa
9.3.5.2 Saudi Arabia
9.3.5.3 UAE
9.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
9.4.1 North America
9.4.2 Europe
9.4.3 Latin America
9.4.4 Asia Pacific
9.4.5 Middle East & Africa
9.5 Market Size & Forecasts, and Trend Analysis, 2020 to 2027
9.5.1 North America
9.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.5.1.2 U.S.
9.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.1.2.2 U.S. Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.1.2.3 U.S. Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.1.2.4 U.S. Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.1.3 Canada
9.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.1.3.2 Canada Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.1.3.3 Canada Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.1.3.4 Canada Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.2 Europe
9.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.5.2.2 U.K.
9.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.2.2.2 U.K. Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.2.2.3 U.K. Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.2.2.4 U.K. Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.2.3 Germany
9.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.2.3.2 Germany Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.2.3.3 Germany Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.2.3.4 Germany Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.2.4 Spain
9.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.2.4.2 Spain Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.2.4.3 Spain Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.2.4.4 Spain Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.2.5 France
9.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.2.5.2 France Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.2.5.3 France Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.2.5.4 France Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.2.6 Italy
9.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.2.6.2 Italy Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.2.6.3 Italy Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.2.6.4 Italy Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.2.7 Russia
9.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.2.7.2 Russia Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.2.7.3 Russia Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.2.7.4 Russia Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.3 Latin America
9.5.3.1 Latin America Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.5.3.2 Brazil
9.5.3.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.3.2.2 Brazil Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.3.2.3 Brazil Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.3.2.4 Brazil Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.3.3 Mexico
9.5.3.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.3.3.2 Mexico Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.3.3.3 Mexico Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.3.3.4 Mexico Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.3.4 Argentina
9.5.3.4.1 Argentina Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.3.4.2 Argentina Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.3.4.3 Argentina Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.3.4.4 Argentina Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.4 Asia Pacific
9.5.4.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.5.4.2 Japan
9.5.4.2.1 Japan Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.4.2.2 Japan Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.4.2.3 Japan Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.4.2.4 Japan Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.4.3 China
9.5.4.3.1 China Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.4.3.2 China Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.4.3.3 China Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.4.3.4 China Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.4.4 India
9.5.4.4.1 India Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.4.4.2 India Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.4.4.3 India Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.4.4.4 India Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.4.5 South Korea
9.5.4.5.1 South Korea Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.4.5.2 South Korea Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.4.5.3 South Korea Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.4.5.4 South Korea Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.4.6 Singapore
9.5.4.6.1 Singapore Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.4.6.2 Singapore Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.4.6.3 Singapore Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.4.6.4 Singapore Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.4.7 Australia
9.5.4.7.1 Australia Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.4.7.2 Australia Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.4.7.3 Australia Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.4.7.3 Australia Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.5 Middle East & Africa
9.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.5.5.2 South Africa
9.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.5.2.2 South Africa Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.5.2.3 South Africa Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.5.2.4 South Africa Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.5.3 Saudi Arabia
9.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.5.3.2 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.5.3.3 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.5.3.4 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
9.5.5.4 UAE
9.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD million)
9.5.5.4.2 UAE Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD million)
9.5.5.4.3 UAE Market Size & Forecasts and Trend Analysis, By Pathogen, 2016 to 2027 (USD million)
9.5.5.4.4 UAE Market Size & Forecasts and Trend Analysis, By Testing Type, 2016 to 2027 (USD million)
Chapter 10 Company Profiles
10.1 Company Profiles
10.1.1 bioMérieux SA
10.1.1.1 Company overview
10.1.1.2 Financial Performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 Becton, Dickinson and Company (BD)
10.1.2.1 Company overview
10.1.2.2 Financial Performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 Thermo Fisher Scientific, Inc.
10.1.3.1 Company overview
10.1.3.2 Financial Performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 F. Hoffmann-La Roche
10.1.4.1 Company overview
10.1.4.2 Financial Performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 Luminex Corporation
10.1.5.1 Company overview
10.1.5.2 Financial Performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 Danaher
10.1.6.1 Cepheid
10.1.6.1.1 Company overview
10.1.6.1.2 Financial Performance
10.1.6.1.3 Product benchmarking
10.1.6.1.4 Strategic initiatives
10.1.6.2 Beckman Coulter, Inc.
10.1.6.2.1 Company overview
10.1.6.2.2 Financial Performance
10.1.6.2.3 Product benchmarking
10.1.6.2.4 Strategic initiatives
10.1.7 Luminex Corporation
10.1.7.1 Company overview
10.1.7.2 Financial Performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 Bruker Corporation
10.1.8.1 Company overview
10.1.8.2 Financial Performance
10.1.8.3 Product benchmarking
10.1.8.4 Strategic initiatives
10.1.9 Amara Health Analytics
10.1.9.1 Company overview
10.1.9.2 Financial Performance
10.1.9.3 Product benchmarking
10.1.9.4 Strategic initiatives
10.1.10 Wolters Kluwer N.V.
10.1.10.1 Company overview
10.1.10.2 Financial Performance
10.1.10.3 Product benchmarking
10.1.10.4 Strategic initiatives
10.1.11 Cerner Corporation
10.1.11.1 Company overview
10.1.11.2 Financial Performance
10.1.11.3 Product benchmarking
10.1.11.4 Strategic initiatives
10.1.12 Epic Systems Corporation
10.1.12.1 Company overview
10.1.12.2 Financial Performance
10.1.12.3 Product benchmarking
10.1.12.4 Strategic initiatives
10.1.13 McKesson Corporation
10.1.13.1 Company overview
10.1.13.2 Financial Performance
10.1.13.3 Product benchmarking
10.1.13.4 Strategic initiatives
10.1.14 GE Healthcare
10.1.14.1 Company overview
10.1.14.2 Financial Performance
10.1.14.3 Product benchmarking
10.1.14.4 Strategic initiatives
10.1.15 Koninklijke Philips N.V.
10.1.15.1 Company overview
10.1.15.2 Financial Performance
10.1.15.3 Product benchmarking
10.1.15.4 Strategic initiatives

List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 North America sepsis diagnostics market estimates and forecasts, by country, 2016 - 2027 (USD Million)
Table 4 North America sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 5 North America sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 6 North America sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 7 North America sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 8 North America sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 9 U.S. sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 10 U.S. sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 11 U.S. sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 12 U.S. sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 13 U.S. sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 14 Canada sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 15 Canada sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 16 Canada sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 17 Canada sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 18 Canada sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 19 Europe sepsis diagnostics market estimates and forecasts, by country, 2016 - 2027 (USD Million)
Table 20 Europe sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 21 Europe sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 22 Europe sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 23 Europe sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 24 Europe sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 25 Germany sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 26 Germany sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 27 Germany sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 28 Germany sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 29 Germany sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 30 U.K. sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 31 U.K. sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 32 U.K. sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 33 U.K. sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 34 U.K. sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 35 France sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 36 France sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 37 France sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 38 France sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 39 France sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 40 Italy sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 41 Italy sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 42 Italy sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 43 Italy sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 44 Italy sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 45 Spain sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 46 Spain sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 47 Spain sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 48 Spain sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 49 Spain sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 50 Russia sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 51 Russia sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 52 Russia sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 53 Russia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 54 Russia sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 55 Asia Pacific sepsis diagnostics market estimates and forecasts, by country, 2016 - 2027 (USD Million)
Table 56 Asia Pacific sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 57 Asia Pacific sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 58 Asia Pacific sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 59 Asia Pacific sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 60 Asia Pacific sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 61 China sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 62 China sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 63 China sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 64 China sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 65 China sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 66 India sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 67 India sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 68 India sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 69 India sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 70 India sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 71 Australia sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 72 Australia sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 73 Australia sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 74 Australia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 75 Australia sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 76 Japan sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 77 Japan sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 78 Japan sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 79 Japan sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 80 Japan sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 81 South Korea sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 82 South Korea sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 83 South Korea sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 84 South Korea sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 85 South Korea sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 86 Singapore sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 87 Singapore sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 88 Singapore sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 89 Singapore sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 90 Singapore sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 91 Latin America sepsis diagnostics market estimates and forecasts, by country, 2016 - 2027 (USD Million)
Table 92 Latin America sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 93 Latin America sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 94 Latin America sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 95 Latin America sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 96 Latin America sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 97 Brazil sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 98 Brazil sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 99 Brazil sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 100 Brazil sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 101 Brazil sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 102 Mexico sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 103 Mexico sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 104 Mexico sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 105 Mexico sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 106 Mexico sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 107 Argentina sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 108 Argentina sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 109 Argentina sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 110 Argentina sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 111 Argentina sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 112 MEA sepsis diagnostics market estimates and forecasts, by country, 2016 - 2027 (USD Million)
Table 113 MEA sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 114 MEA sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 115 MEA sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 116 MEA sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 117 MEA sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 118 South Africa sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 119 South Africa sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 120 South Africa sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 121 South Africa sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 122 South Africa sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 123 Saudi Arabia sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 124 Saudi Arabia sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 125 Saudi Arabia sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 126 Saudi Arabia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 127 Saudi Arabia sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)
Table 128 UAE sepsis diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 129 UAE sepsis diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 130 UAE sepsis diagnostics market estimates and forecasts, by pathogen, 2016 - 2027 (USD Million)
Table 131 UAE sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2016 - 2027 (USD Million)
Table 132 UAE sepsis diagnostics market estimates and forecasts, by testing type, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot, 2020 (USD Million)
Fig. 9 Sepsis diagnostics market segmentation
Fig. 10 Penetration & growth prospect mapping for product, 2020
Fig. 11 Penetration & growth prospect mapping for technology, 2020
Fig. 12 Penetration & growth prospect mapping for pathogen, 2020
Fig. 13 Penetration & growth prospect mapping for testing type, 2020
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Company/competition categorization (key innovators, market leaders, emerging players)
Fig. 17 Strategy framework
Fig. 18 Market participation categorization
Fig. 19 Company position analysis
Fig. 20 Sepsis diagnostics market: Product outlook and key takeaways
Fig. 21 Sepsis diagnostics market: Product movement analysis
Fig. 22 Instruments market, 2016 - 2027 (USD Million)
Fig. 23 Blood culture media market, 2016 - 2027 (USD Million)
Fig. 24 Assay kits & reagents market, 2016 - 2027 (USD Million)
Fig. 25 Software market, 2016 - 2027 (USD Million)
Fig. 26 Sepsis diagnostics market: Technology outlook and key takeaways
Fig. 27 Sepsis diagnostics market: Technology movement analysis
Fig. 28 Microbiology market, 2016 - 2027 (USD Million)
Fig. 29 Molecular diagnostics market, 2016 - 2027 (USD Million)
Fig. 30 Immunoassays market, 2016 - 2027 (USD Million)
Fig. 31 Flow cytometry market, 2016 - 2027 (USD Million)
Fig. 32 Sepsis diagnostics market: Pathogen outlook and key takeaways
Fig. 33 Sepsis diagnostics market: Pathogen movement analysis
Fig. 34 Bacterial sepsis market, 2016 - 2027 (USD Million)
Fig. 35 Gram-negative bacterial sepsis market, 2016 - 2027 (USD Million)
Fig. 36 Gram-positive bacterial sepsis market, 2016 - 2027 (USD Million)
Fig. 37 Fungal sepsis market, 2016 - 2027 (USD Million)
Fig. 38 Other pathogenic sepsis market, 2016 - 2027 (USD Million)
Fig. 39 Sepsis diagnostics market: Testing type outlook and key takeaways
Fig. 40 Sepsis diagnostics market: Testing type movement analysis
Fig. 41 Laboratory testing market, 2016 - 2027 (USD Million)
Fig. 42 Point-of-care testing market, 2016 - 2027 (USD Million)
Fig. 43 Sepsis diagnostics market: Regional outlook and key takeaways
Fig. 44 Sepsis diagnostics market: Regional movement analysis
Fig. 45 North America
Fig. 46 North America sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 47 U.S.
Fig. 48 U.S. sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 49 Canada
Fig. 50 Canada sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 51 Europe
Fig. 52 Europe sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 53 Germany
Fig. 54 Germany sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 55 U.K.
Fig. 56 U.K. sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 57 France
Fig. 58 France sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 59 Italy
Fig. 60 Italy sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 61 Spain
Fig. 62 Spain sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 63 Russia
Fig. 64 Russia sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 65 Asia Pacific
Fig. 66 Asia Pacific sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 67 Japan
Fig. 68 Japan sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 69 China
Fig. 70 China sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 71 India
Fig. 72 India sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 73 South Korea
Fig. 74 South Korea sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 75 Australia
Fig. 76 Australia sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 77 Singapore
Fig. 78 Singapore sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 79 Latin America
Fig. 80 Latin America sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 81 Brazil
Fig. 82 Brazil sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 83 Mexico
Fig. 84 Mexico sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 85 Argentina
Fig. 86 Argentina sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 87 MEA
Fig. 88 MEA sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 89 South Africa
Fig. 90 South Africa sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 91 Saudi Arabia
Fig. 92 Saudi Arabia sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 93 UAE
Fig. 94 UAE sepsis diagnostics market estimates and forecast, 2016 - 2027 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の敗血症診断市場2021-2027:製品別(血液培養培地、ソフトウェア、機器、アッセイキット・試薬)、技術別、病原体別、検査タイプ別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆